(Q41454994)

30 September 2017

1 reference

title

Post-transplant EBV induced lymphoproliferative disorders (English)

1 reference

30 September 2017

Lucas KG

1

1 reference

PubMed ID

9130609

30 September 2017

Pollok KE

series ordinal

2

1 reference

PubMed ID

9130609

30 September 2017

Emanuel DJ

series ordinal

3

1 reference

30 September 2017

1 March 1997

1 reference

30 September 2017

1 reference

30 September 2017

25

1 reference

30 September 2017

1-2

1 reference

30 September 2017

1-8

1 reference

Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies

30 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

The short unique region of the B95-8 Epstein-Barr virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Epstein-Barr virus and human diseases: recent advances in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Phenotype of recovering lymphoid cell populations after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

The diagnosis and treatment of posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709042491

10.3109/10428199709042491

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9130609